Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection

Cellular Microbiology

Volumn 18, Issue 12, 2016, Pages 1739-1750

  Peng, Kaitian ^a   Goh, Yun Shan ^a   Siau, Anthony ^b   Franetich, Jean François ^c,d   Chia, Wan Ni ^a,e   Ong, Alice Soh Meoy ^a   Malleret, Benoit ^a   Wu, Ying Ying ^a   Snounou, Georges ^c,d   Hermsen, Cornelus C ^f   Adams, John H ^g   Mazier, Dominique ^c,d,h   Preiser, Peter R ^b   Sauerwein, Robert W ^f   Grüner, Anne Charlotte ^a   Rénia, Laurent ^a,e  

^a AGENCY FOR SCIENCE   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GENOMIC DNA; GENOMIC RNA; MALARIA VACCINE; NEUTRALIZING ANTIBODY; PFMAEBL ANTIGEN; PFSEA1 ANTIGEN; PFTRAP ANTIGEN; PROTOZOON ANTIBODY; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ANTISERUM; CELL SURFACE RECEPTOR; CHLOROQUINE; MAEBL PROTEIN, PLASMODIUM FALCIPARUM; PARASITE ANTIGEN; PEPTIDE LIBRARY; PROTOZOAL PROTEIN; SEA-1 PROTEIN, PLASMODIUM FALCIPARUM; THROMBOSPONDIN-RELATED ADHESIVE PROTEIN, PROTOZOAN;

ADULT; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNIZATION; LIVER CELL; MALARIA; MALARIA CONTROL; PLASMODIUM FALCIPARUM 3D7; PRIORITY JOURNAL; PROTOZOAL GENETICS; SPOROZOITE; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CROSS REACTION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; MALARIA, FALCIPARUM; PARASITOLOGY; PEPTIDE LIBRARY; PLASMODIUM FALCIPARUM; VACCINATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ANTIMALARIALS; CHLOROQUINE; CROSS REACTIONS; GENE EXPRESSION; HEPATOCYTES; HUMANS; IMMUNE SERA; IMMUNITY, HUMORAL; MALARIA VACCINES; MALARIA, FALCIPARUM; PEPTIDE LIBRARY; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; SPOROZOITES; VACCINATION;

EID: 84971277140     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12608     Document Type: Article

References (68)

1. Arama, C., Skinner, J., Doumtabe, D., Portugal, S., Tran, T.M., Jain, A., et al. (2015) Genetic resistance to malaria is associated with greater enhancement of immunoglobulin (Ig)M than IgG responses to a broad array of Plasmodium falciparum antigens. Open Forum Infect Dis 2: ofv118.
2. Baer, K., Klotz, C., Kappe, S.H., Schnieder, T., and Frevert, U. (2007) Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog 3: e171.
3. Behet, M.C., Foquet, L., van Gemert, G.J., Bijker, E.M., Meuleman, P., Leroux-Roels, G., et al. (2014) Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Malar J 13: 136.
4. Bejon, P., White, M.T., Olotu, A., Bojang, K., Lusingu, J.P., Salim, N., et al. (2013) Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. Lancet Infect Dis 13: 319–327.
5. Belnoue, E., Costa, F.T.M., Frankenberg, T., Vigario, A.M., Voza, T., Leroy, N., et al. (2004) Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 172: 2487–2495.
6. Bijker, E.M., Bastiaens, G.J., Teirlinck, A.C., van Gemert, G.J., van de Graumans, W., et al. (2013) Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc Natl Acad Sci U S A 110: 7862–7867.
7. Bijker, E.M., Teirlinck, A.C., Schats, R., van Gemert, G.J., van de Vegte-Bolmer, M., et al. (2014) Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites. J Infect Dis 210: 1605–1615.
8. Bouharoun-Tayoun, H., Attanath, P., Sabchareon, A., Chongsuphajaisiddhi, T., and Druilhe, P. (1990) Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 172: 1633–1641.
9. Boyle, M.J., Reiling, L., Feng, G., Langer, C., Osier, F.H., Aspeling-Jones, H., et al. (2015) Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria. Immunity 42: 580–590.
10. Charoenvit, Y., Fallarme, V., Rogers, W.O., Sacci, J.B., Jr., Kaur, M., Aguiar, J.C., et al. (1997) Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes. Infect Immun 65: 3430–3437.
11. Chia, W.N., Goh, Y.S., and Renia, L. (2014) Novel approaches to identify protective malaria vaccine candidates. Front Microbiol 5: 586.
12. Cohen, S., McGregor, I.A., and Carrington, S. (1961) Gamma-globulin and acquired immunity to human malaria. Nature 192: 733–737.
13. Culleton, R.L., Inoue, M., Reece, S.E., Cheesman, S., and Carter, R.L. (2011) Strain-specific immunity induced by immunization with pre-erythrocytic stages of Plasmodium chabaudi. Parasite Immunol 33: 73–78.
14. Do Rosario, V.E. (1981) Cloning of naturally occurring mixed infections of malaria parasites. Science 212: 1037–1038.
15. Doolan, D.L., Mu, Y., Unal, B., Sundaresh, S., Hirst, S., Valdez, C., et al. (2008) Profiling humoral immune responses to Plasmodium falciparum infection with protein microarrays. Proteomics 8: 4680–4694.
16. Duncan, C.J., Hill, A.V.S., and Ellis, R.D. (2012) Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy? Hum Vaccin Immunother 8: 706–714.
17. Edozien, J.C., Gilles, H.M., and Udeozo, I.O.K. (1962) Adult and cord-blood gamma-globulin and immunity to malaria in Nigerians. Lancet 280: 951–955.
18. Felgner, P.L., Roestenberg, M., Liang, L., Hung, C., Jain, A., Pablo, J., et al. (2013) Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis. Sci Rep 3: 3549.
19. Fourmaux, M.N., Achbarou, A., Mercereau-Puijalon, O., Biderre, C., Briche, I., Loyens, A., et al. (1996) The MIC1 microneme protein of Toxoplasma gondii contains a duplicated receptor-like domain and binds to host cell surface. Mol Biochem Parasitol 83: 201–210.
20. Friesen, J., Silvie, O., Putrianti, E.D., Hafalla, J.C.R., Matuschewski, K., and Borrmann, S. (2010) Natural immunization against malaria: causal prophylaxis with antibiotics. Sci Transl Med 2: 40ra49.
21. Friesen, J., Borrmann, S., and Matuschewski, K. (2011) Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistance. Antimicrob Agents Chemother 55: 2760–2767.
22. Gego, A., Silvie, O., Franetich, J.F., Farhati, K., Hannoun, L., Luty, A.J.F., et al. (2006) New approach for high-throughput screening of drug activity on Plasmodium liver stages. Antimicrob Agents Chemother 50: 1586–1589.
23. Greenwood, B.M., Fidock, D.A., Kyle, D.E., Kappe, S.H., Alonso, P.L., Collins, F.H., et al. (2008) Malaria: progress, perils, and prospects for eradication. J Clin Invest 118: 1266–1276.
24. Gruner, A.C., Mauduit, M., Tewari, R., Romero, J.F., Depinay, N., Kayibanda, M., et al. (2007) Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS One 2: e1371.
25. Gustafsson, L.L., Walker, O., Alvan, G., Beermann, B., Estevez, F., Gleisner, L., et al. (1983) Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 15: 471–479.
26. Herrington, D.A., Hoffman, S.L., Levine, M.M., and Gordon, D.M. (1990) Malaria vaccines. Science 248: 422.
27. Hoffman, S.L., Goh, L.M., Luke, T.C., Schneider, I., Le, T.P., Doolan, D.L., et al. (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185: 1155–1164.
28. John, C.C., Zickafoose, J.S., Sumba, P.O., King, C.L., and Kazura, J.W. (2003) Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya. Infect Immun 71: 4320–4325.
29. John, C.C., Moormann, A.M., Pregibon, D.C., Sumba, P.O., McHugh, M.M., Narum, D.L., et al. (2005) Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. Am J Trop Med Hyg 73: 222–228.
30. Joos, C., Marrama, L., Polson, H.E., Corre, S., Diatta, A.M., Diouf, B., et al. (2010) Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies. PLoS One 5: e9871.
31. Kinyanjui, S.M., Bull, P.C., Newbold, C.I., and Marsh, K. (2003) Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J Infect Dis 187: 667–674.
32. Kumar, K.A., Sano, G., Boscardin, S.B., Nussenzweig, R.S., Nussenzweig, M.C., Zavala, F., et al. (2006) The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444: 937–940.
33. Kurtis, J.D., Lanar, D.E., Opollo, M.O., and Duffy, P.E. (1999) Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum. Infect Immun 67: 3424–3429.
34. Langhorne, J., Ndungu, F.M., Sponaas, A.M., and Marsh, K. (2008) Immunity to malaria: more questions than answers. Nat Immunol 9: 725–732.
35. Le Roch, K.G., Johnson, J.R., Florens, L., Zhou, Y., Santrosyan, A., Grainger, M., et al. (2004) Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res 14: 2308–2318.
36. Longley, R.J., Hill, A.V.S., and Spencer, A.J. (2015) Malaria vaccines: identifying liver-stage targets. Front Microbiol 6: 965.
37. Malleret, B., Claser, C., Ong, A.S., Suwanarusk, R., Sriprawat, K., Howland, S.W., et al. (2011) A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci Rep 1: 118.
38. Mauduit, M., Tewari, R., Depinay, N., Kayibanda, M., Lallemand, E., Chavatte, J.M., et al. (2010) A minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Infect Immun 70: 2182–2188.
39. McGregor, I.A. (1987) Malarial immunity: current trends and prospects. Ann Trop Med Parasitol 81: 647–656.
40. Nahrendorf, W., Scholzen, A., Bijker, E.M., Teirlinck, A.C., Bastiaens, G.J., Schats, R., et al. (2014) Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization. J Infect Dis 210: 1981–1990.
41. Nebie, I., Tiono, A.B., Diallo, D.A., Samandoulougou, S., Diarra, A., Konate, A.T., et al. (2008) Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria? Trop Med Int Health 13: 229–237.
42. Nussenzweig, R.S., and Nussenzweig, V. (1984) Development of sporozoite vaccines. Philos Trans R Soc Lond B Biol Sci 307: 117–128.
43. Osier, F.H., Feng, G., Boyle, M.J., Langer, C., Zhou, J., Richards, J.S., et al. (2014) Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria. BMC Med 12: 108.
44. Penny, M.A., Galactionova, K., Tarantino, M., Tanner, M., and Smith, T.A. (2015) The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models. BMC Med 13: 170.
45. Ponnudurai, T., Meuwissen, J.H.E.T., Leeuwenberg, A.D.E.M., Verhave, J.P., and Lensen, A.H.W. (1982) The production of mature gametocytes of Plasmodium falciparum in continuous cultures of different isolates infective to mosquitoes. Trans R Soc Trop Med Hyg 76: 242–250.
46. Ponnudurai, T., Lensen, A.H.W., van Gemert, G.J., Bolmer, M., Van Belkum, A., van Eerd, P., et al. (1990) Large-scale production of Plasmodium vivax sporozoites. Parasitology 101: 317–320.
47. Preiser, P.R., Renia, L., Singh, N., Balu, B., Jarra, W., Voza, T., et al. (2004) Antibodies against MAEBL ligand domains M1 and M2 inhibit sporozoite development in vitro. Infect Immun 72: 3604–3608.
48. Putrianti, E.D., Silvie, O., Kordes, M., Borrmann, S., and Matuschewski, K. (2009) Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J Infect Dis 199: 899–903.
49. Raj, D.K., Nixon, C.P., Nixon, C.E., Dvorin, J.D., DiPetrillo, C.G., Pond-Tor, S., et al. (2014) Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection. Science 344: 871–877.
50. Renia, L., Mattei, D., Goma, J., Pied, S., Dubois, P., Miltgen, F., et al. (1990) A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells. Eur J Immunol 20: 1445–1449.
51. Renia, L., Gruner, A.C., Mauduit, M., and Snounou, G. (2006) Vaccination against malaria with live parasites. Expert Rev Vaccines 5: 473–481.
52. Renia, L., Gruner, A.C., Mauduit, M., and Snounou, G. (2013) Vaccination using normal live sporozoites under drug treatment. Methods Mol Biol 923: 567–576.
53. Robson, K.J.H., Hall, J.R., Jennings, M.W., Harris, T.J., Marsh, K., Newbold, C.I., et al. (1988) A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 335: 79–82.
54. Roestenberg, M., McCall, M., Hopman, J., Wiersma, J., Luty, A.J.F., van Gemert, G.J., et al. (2009) Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361: 468–477.
55. Rogers, W.O., Malik, A., Mellouk, S., Nakamura, K., Rogers, M.D., Szarfman, A., et al. (1992) Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci U S A 89: 9176–9180.
56. Saenz, F.E., Balu, B., Smith, J., Mendonca, S.R., and Adams, J.H. (2008) The transmembrane isoform of Plasmodium falciparum MAEBL is essential for the invasion of Anopheles salivary glands. PLoS One 3: e2287.
57. Schats, R., Bijker, E.M., van Gemert, G.J., Graumans, W., van de Vegte-Bolmer, M., van Lieshout, L., et al. (2015) Heterologous protection against malaria after immunization with Plasmodium falciparum sporozoites. PLoS One 10: e0124243.
58. Silvie, O., Franetich, J.F., Charrin, S., Mueller, M.S., Siau, A., Bodescot, M., et al. (2004) A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J Biol Chem 279: 9490–9496.
59. Singh, N., Preiser, P.R., Renia, L., Balu, B., Barnwell, J.W., Blair, P., et al. (2004) Conservation and developmental control of alternative splicing in maebl among malaria parasites. J Mol Biol 343: 589–599.
60. Spano, F., Putignani, L., Naitza, S., Puri, C., Wright, S., and Crisanti, A. (1998) Molecular cloning and expression analysis of a Cryptosporidium parvum gene encoding a new member of the thrombospondin family. Mol Biochem Parasitol 92: 147–162.
61. Stoute, J.A., Slaoui, M., Heppner, D.G., Jr., Momin, P., Kester, K.E., Desmons, P., et al. (1997) A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N Engl J Med 336: 86–91.
62. Sturm, A., Amino, R., Van De Sand, C., Regen, T., Retzlaff, S., Rennenberg, A., et al. (2006) Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313: 1287–1290.
63. Tarlinton, D.M., and Good-Jacobson, K.L. (2013) Diversity among memory B cells: origin, consequences, and utility. Science 341: 1205–1211.
64. Teirlinck, A.C., McCall, M.B., Roestenberg, M., Scholzen, A., Woestenenk, R., de Mast, Q., et al. (2011) Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathog 7: e1002389.
65. Tomley, F.M., Billington, K.J., Bumstead, J.M., Clark, J.D., and Monaghan, P. (2001) EtMIC4: a microneme protein from Eimeria tenella that contains tandem arrays of epidermal growth factor-like repeats and thrombospondin type-I repeats. Int J Parasitol 31: 1303–1310.
66. Weiss, G.E., Crompton, P.D., Li, S., Walsh, L.A., Moir, S., Traore, B., et al. (2009) Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol 183: 2176–2182.
67. Zavala, F., Tam, J.P., and Masuda, A. (1986) Synthetic peptides as antigens for the detection of humoral immunity to Plasmodium falciparum sporozoites. J Immunol Methods 93: 55–61.
68. Zhang, Y., Asante, K.S., and Jung, A. (1986) Stage-dependent inhibition of chloroquine on Plasmodium falciparum in vitro. J Parasitol 72: 830–836.